3 Results for "

A-1331852

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "A-1331852" in MCE Product Catalog:

56
56 Cited Publications
Cat. No.: HY-19741
CAS No.: 1430844-80-6
Target:  

Bcl-2 Family

Research Areas:  

Cancer

A-1331852 is an orally available BCL-XL selective inhibitor with a Ki of less than 10 pM.
loading...
    loading...
Cat. No.: HY-172798
Target:  

PROTACs Bcl-2 Family

Research Areas:  

Cancer

XZ338 is a highly potent and selective BCL-XL PROTAC degrader derived from A-1331852 (HY-19741), with a DC50 of 0.43 nM in MOLT‑4 cells. XZ338 induces the formation of a ternary complex with BCL-XL and VHL E3 ligase, mediates target protein degradation via the ubiquitin-proteasome system, and exhibits significantly weaker degradation activity in platelets than in tumor cells. XZ338 possesses anti-cancer activity. XZ338 can be used in the research of T-cell acute lymphoblastic leukemia (T-ALL) .
loading...
    loading...
Cat. No.: HY-184471
CAS No.: 2599098-78-7
Research Areas:  

Cancer

BCL-XL-IN-5 is an orally active, highly selective BH3-mimetic BCL-XL inhibitor with a cKi of 7.96 pM. BCL-XL-IN-5 triggers caspase-3 activation and robust PARP cleavage to initiate apoptosis in BCL-XL-dependent MOLT-4 T-cell acute lymphoblastic leukemia cells. BCL-XL-IN-5 serves as a potent selective probe for investigating BCL-XL-dependent malignancies, such as acute lymphoblastic leukemia .
loading...
    loading...